Skip links and keyboard navigation

RADONC celebrates extraordinary year of research

21 April 2017

The Princess Alexandra Hospital Radiation Oncology Department celebrated a bumper year of achievements with the launch of its 2016 Annual Research Report.

During last year, the RADONC team had 46 peer-review publications, 16 internal presentations, 50 national presentations, two post-doctorates (PhD) and one Master of Philosophy, two national research awards, one academic promotion to full professor, and in collaboration with other investigations the awarding of more than $3.2 million.

Professor Sandro Porceddu, Director Radiation Oncology Research, said over the last few years the department had embraced a research culture.

“Our research portfolio covers the whole spectrum from brain, head and neck, breast, lung, bowel and genito-urinary and looks at translating research findings into immediate clinical impact,” he said.

“So we really are at that interface, where our findings are often translated immediately into practice.”

With a research portfolio of 28 investigator-led collaborative trial group studies, Professor Porceddu said the department continued to partner with other national and international academic institutions and industry to deliver innovation in clinical and translational research.

“We also have 42 in-house research projects by registrars, radiation oncology clinical research fellows, research high degree candidates, radiation therapists, medical physicists, oncology nursing, allied health professionals and a Queensland Health Office of Health and Medical Research Fellow.”

Professor Porceddu said the department had also obtained a number of successful outcomes.

“Elizabeth Brown obtained her PhD through QUT, and Laurelie Wall did most of her research with us, and we claim her as our own, was also successfully awarded a PhD through UQ,” he said.

“We’ve also won awards for our scientific papers.

“Elizabeth Brown also won Best Radiation Therapy Research Paper from the Australian Society of Medical Imaging and Radiation Therapy.

“And Bena Cartmill won Best Research Paper (Allied Health) from the ANZ Head and Neck Cancer Society for her ScreenIT project—and that is a very competitive award to win.

“One of things with ScreenIT is, although we’re are viewed as a technical speciality we actually demonstrated that we can have an impact into health economics and produce cost-effective treatment and it’s now being rolled out into other areas of cancer.”

Last updated 21 April 2017
Last reviewed 21 April 2017

Other news

Bowel cancer early detection is key

Bowel Cancer—early detection is key

Bowel cancer is Australia’s second biggest cancer killer but is one of the most treatable types if found early. This Bowel Cancer Awareness Month Princess Alexandra Hospital Health Promotion Officer Abby Fraser was encouraging the community to ‘Make No. 2 your No. 1 priority’ and participate in the free National Bowel Cancer Screening Program.

Dr Darshan Shah clot dissolving drug trial for stroke patients

Trial tests time-saving clot-dissolving drug

A clot-dissolving drug trial could see stroke patients receive life-saving treatment faster. The Princess Alexandra Hospital Stroke Unit was participating in a trial that aimed to show Tenecteplase, a clot-dissolving drug currently used in heart attack patients, could reduce treatment time for stroke patients by an hour.